Weak PE activity drags down overall deals in May A total of 107 deals were transacted in May with a value of $1.8 billion and the average was at $17.2 million, down from $21.5 million in April ...

Phase 1 and interim phase 2 data met GSK’s immunogenicity success criteria, the London-based drugmaker said. Yet, GSK has decided to hand off to India’s Bharat for the phase 3 trial.

Maruti Suzuki India Limited has received a 5-star safety rating for its All-New Dzire under the Bharat New Car Assessment Program (Bharat NCAP). The rating was presented by Nitin Gadkari, Minister ...

Prayagraj: In a significant push to improve foundational literacy and numeracy among young learners, the NIPUN Bharat Mission is being implemented with renewed vigour in the basic schools of ...

DRDO licenses nine advanced defence technologies to Bharat Electronics, BEML, Bharat Forge, Tata Advanced Systems, and others, accelerating Make in India and strengthening India’s defence ...

Prime Minister Narendra Modi launched the Patliputra–Gorakhpur Vande Bharat Express, enhancing connectivity between key North Indian cities. This semi-high-speed train, operating six days a week ...

NEW DELHI: The Wealth Company Asset Management, part of the Pantomath Group, has launched Bharat Bhoomi Fund —a ₹1,000 crore category II AIF with a ₹1,000 crore green shoe option—under its fifth ...

Bharat Biotech joins GSK to develop a Shigella vaccine to fight shigellosis in children, with Phase 3 trials underway and focus on low-income countries.

A needless controversy over ‘Bharat Mata’ Premium The RSS cannot foist its ideological and political preoccupations upon official functions Updated - June 12, 2025 01:59 pm IST ...

KOLKATA: Two major companies, Dalmia Bharat Ltd and Birla Corporation, said that about Rs 430 crore in promised state incentives may now be at risk after the West Bengal government scrapped several ...